![Yoshinori Oikawa](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshinori Oikawa active positions
Companies | Position | Start | End |
---|---|---|---|
Emendo Biotherapeutics, Inc.
![]() Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Director/Board Member | - | - |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Chairman | - | - |
Director/Board Member | 2018-12-31 | - |
Career history of Yoshinori Oikawa
Statistics
International
United States | 2 |
Israel | 2 |
Operational
Director/Board Member | 2 |
Chairman | 1 |
Sectoral
Health Technology | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Private companies | 2 |
---|---|
Emendo Biotherapeutics, Inc.
![]() Emendo Biotherapeutics, Inc. BiotechnologyHealth Technology Emendo Biotherapeutics, Inc. engages in the development of genome editing technology. It specializes in protein engineering, molecular biology, and gene editing systems. The company was founded by David Baram, Lior Izhar, and Rachel Diamant in 2015 and is headquartered in New York, NY. | Health Technology |
MyBiotics Pharma Ltd.
![]() MyBiotics Pharma Ltd. BiotechnologyHealth Technology MyBiotics Pharma Ltd. operates as a micro biome pharmaceutical company that develops live bacteria based drugs. It develops MyCrobe and SuperDonor technologies for growing specific bacterial communities on pre-selected particles for stable and resistant raw material and for multi bacterial products. The company was founded in and is headquartered in Ness Ziona, Israel. | Health Technology |
- Stock Market
- Insiders
- Yoshinori Oikawa
- Experience